Primary Record
vintafolide
- In stock
- 3,359 g
- Purity
- 98.2 %
- CAS
- 742092-03-1
Compound Identifiers & Properties
- CAS
- 742092-03-1
- PubChem CID
- 25014653
- SMILES
- CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)NNC(=O)OCCSSC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)CC[C@@H](C(=O)O)NC(=O)C1=CC=C(C=C1)NCC1=CN=C2C(=N1)C(=O)NC(=N2)N)O)O)CC)OC)C(=O)OC)O
- Canonical SMILES
- CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)CC[C@H](NC(=O)c5ccc(NCc6cnc7nc(N)[nH]c(=O)c7n6)cc5)C(=O)O)C(=O)O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
Names & Synonyms
- vintafolide
- Vynfinit
- vintafolida
- vintafolidum
- Vintafolide [USAN]
- EC145
- Vintafolide [USAN:INN]
- RefChem:194302
- VINTAFOLIDE [INN]
- EC-145
- D09JGH
- UNII-36O410ZD4I
- 36O410ZD4I
- VINTAFOLIDE [WHO-DD]
- DTXSID201030294
- 742092-03-1
- SCHEMBL18909586
- SCHEMBL30314561
- L01CA06
- EC 145
- DTXCID001515391
- EC-0255
- EC-0260
- Folate-Vinca Alkaloid Conjugate EC145
- CID:25014653
- SID:53787001
- C520389
- Desacetylvinblastine hydrazide conjugate with Folic acid
- Q7932801
- (2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-5-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(1R)-1-carboxy-2-[2-[[[(1R,9R,10S,11R,12R,19R)-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carbonyl]amino]carbamoyloxy]ethyldisulfanyl]ethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
- (2R,3Z,5S,6Z,8S,9Z,11S,12Z,14S,15Z,19S)-5,8,14-tris(carboxymethyl)-2-(((2-((E)-((Z)-(((3aR,3a1S,4R,5S,5aR,10bR)-3a-ethyl-9-((5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl
- (2S)-5-((2S)-1-((2S)-5-carbamimidamido-1-((2S)-3-carboxy-1-((2S)-3-carboxy-1-((1R)-1-carboxy-2-(2-(N-((((1R,9R,10S,11R,12R,19R)-12-ethyl-4-((13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo(13.3.1.04,12.05,10)nonadeca-4(12),5,7,9-tetraen-13-yl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo(10.6.1.01,9.02,7.016,19)nonadeca-2,4,6,13-tetraen-10-yl)-hydroxymethylidene)amino)-C-hydroxycarbonimidoyl)oxyethyldisulfanyl)ethyl)imino-1-hydroxypropan-2-yl)imino-1-hydroxypropan-2-yl)imino-1-hydroxypentan-2-yl)imino-3-carboxy-1-hydroxypropan-2-yl)imino-5-hydroxy-2-((4-((4-hydroxy-2-imino-1H-pteridin-6-yl)methylamino)benzoyl)amino)pentanoic acid
- N-(4-(((2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl)amino)benzoyl)-L-alpha-glutamyl-L-alpha-aspartyl-L-arginyl-L-alpha-aspartyl-L-alpha-aspartyl-L-cysteine disulfide with methyl (5S,7R,9S)- 5-ethyl-9-((3aR,4R,5S,5aR,10bR,13aR)-3a-ethyl-4,5-dihydroxy-8-methoxy-6-methyl-5- ((2-((2-sulfanylethoxy)carbonyl)hydrazinyl)carbonyl)-3a,4,5,5a,6,11,12,13a-octahydro- 1H-indolizino(8,1-cd)carbazol-9-yl)-5-hydroxy-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-carboxylate
- Vincaleukoblastin-23-oic acid, O4-deacetyl-, 2-((2-mercaptoethoxy)carbonyl)hydrazide, disulfide with N-(4-(((2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-alpha-glutamyl-L-alpha-aspartyl-L-arginyl-L-alpha-aspartyl-L-alpha-aspartyl-L-cysteine